Literature DB >> 11909717

New aromatase inhibitors. Synthesis and inhibitory activity of pyridinyl-substituted flavanone derivatives.

Christelle Pouget1, Catherine Fagnere, Jean-Philippe Basly, Gerard Habrioux, Albert-José Chulia.   

Abstract

Two (E)-pyridinyl-substituted flavanone derivatives were synthesized and UV irradiation of these compounds afforded a Z-enriched mixture. These products were tested for their ability to inhibit the cytochrome P450 aromatase. It was observed that the introduction of a pyridinylmethylene group at carbon 3 on flavanone nucleus led to a significant increase of aromatase inhibitory effect. Moreover, configuration had a substantial influence on the aromatase inhibitory activity since (E)-isomers were found to be more active than (Z)-isomers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11909717     DOI: 10.1016/s0960-894x(02)00072-0

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

Review 1.  Natural products as aromatase inhibitors.

Authors:  Marcy J Balunas; Bin Su; Robert W Brueggemeier; A Douglas Kinghorn
Journal:  Anticancer Agents Med Chem       Date:  2008-08       Impact factor: 2.505

2.  Synthesis of benzyl substituted naphthalenes from benzylidene tetralones.

Authors:  Lorraine M Deck; Quintino Mgani; Andrea Martinez; Alice Martinic; Lisa J Whalen; David L Vander Jagt; Robert E Royer
Journal:  Tetrahedron Lett       Date:  2012-01-25       Impact factor: 2.415

3.  Synthesis and evaluation of flavanones as anticancer agents.

Authors:  Y Murti; P Mishra
Journal:  Indian J Pharm Sci       Date:  2014-03       Impact factor: 0.975

4.  Organocatalyzed, Photoredox Heteroarylation of 2-Trifluoroboratochromanones via C-H Functionalization.

Authors:  Jennifer K Matsui; Gary A Molander
Journal:  Org Lett       Date:  2017-02-03       Impact factor: 6.005

5.  New chroman-4-one/thiochroman-4-one derivatives as potential anticancer agents.

Authors:  Seref Demirayak; Leyla Yurttas; Nalan Gundogdu-Karaburun; Ahmet Cagri Karaburun; Ismail Kayagil
Journal:  Saudi Pharm J       Date:  2017-04-26       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.